Azenta posts Q4 2026 results, raises FY2027 revenue outlook
Azenta reported fourth‑quarter 2026 revenue of $167 million, a 5% year‑over‑year increase and 2% organic growth. Adjusted diluted EPS for the quarter was $0.28 and total diluted EPS was $0.16. The company guided fiscal 2027 revenue to $648 million‑$660 million and said adjusted EBITDA margin will expand 200‑250 basis points. It also completed the sale of B Medical Systems on July 1 2026 and received full repayment of a $35 million vendor loan on September 3 2026.
Why it matters
The revenue and earnings beat, together with a FY2027 outlook above consensus, prompted the stock to jump about 8‑10% in after‑hours trading. The guidance suggests higher top‑line growth and margin expansion for investors.
Key facts
- 1Q4 2026 revenue was $167 million, up 5% year over year. prnewswire.com
- 2Q4 2026 organic revenue grew 2% year over year. prnewswire.com
- 3Adjusted diluted EPS for Q4 2026 was $0.28. prnewswire.com
- 4Total diluted EPS for Q4 2026 was $0.16. prnewswire.com
- 5Fiscal 2026 revenue was $622 million, up 5% year over year. prnewswire.com
- 6Fiscal 2027 revenue is expected to range from $648 million to $660 million. prnewswire.com
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.